Avidity Partners Management LP Sells 495,990 Shares of Trave

Avidity Partners Management LP cut its holdings in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 37.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 827,010 shares of the company’s stock after selling 495,990 shares during the period. Avidity Partners Management […]

Related Keywords

, Nasdaq , Dynamic Technology Lab Private Ltd , Travere Therapeutics Inc , Charles Schwab Investment Management Inc , Canaccord Genuity Group , Wells Fargo Company , Vanguard Group Inc , Schonfeld Strategic Advisors , Jacobs Levy Equity Management Inc , Exchange Commission , Avidity Partners Management , Travere Therapeutics , Free Report , Partners Management , Strategic Advisors , Levy Equity Management , Technology Lab Private Ltd , Charles Schwab Investment Management , Schwab Investment Management , Genuity Group , Therapeutics Stock Down , Get Free Report , Iga Nephropathy , Visit Holdingschannel , Travere Therapeutics Daily ,